Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Cortex | 6 | 2012 | 274 | 0.940 |
Why?
|
| Biomedical Research | 2 | 2023 | 371 | 0.800 |
Why?
|
| Exploratory Behavior | 3 | 2012 | 72 | 0.800 |
Why?
|
| Students | 2 | 2023 | 452 | 0.780 |
Why?
|
| Engineering | 2 | 2019 | 7 | 0.670 |
Why?
|
| Mathematics | 2 | 2019 | 42 | 0.660 |
Why?
|
| Science | 2 | 2019 | 17 | 0.660 |
Why?
|
| Medial Forebrain Bundle | 2 | 2007 | 2 | 0.600 |
Why?
|
| Prosencephalon | 2 | 2007 | 25 | 0.570 |
Why?
|
| Stress, Psychological | 2 | 2012 | 541 | 0.570 |
Why?
|
| Serotonin | 2 | 2007 | 114 | 0.570 |
Why?
|
| Maternal Deprivation | 2 | 2012 | 7 | 0.540 |
Why?
|
| Mice, Inbred BALB C | 7 | 2012 | 649 | 0.460 |
Why?
|
| Behavior, Animal | 3 | 2019 | 304 | 0.450 |
Why?
|
| Animals, Newborn | 6 | 2012 | 323 | 0.450 |
Why?
|
| Locomotion | 1 | 2012 | 91 | 0.410 |
Why?
|
| Stress, Physiological | 1 | 2012 | 137 | 0.390 |
Why?
|
| Minority Groups | 3 | 2023 | 537 | 0.390 |
Why?
|
| Fear | 1 | 2012 | 234 | 0.350 |
Why?
|
| Dopamine | 2 | 2009 | 232 | 0.340 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2007 | 298 | 0.340 |
Why?
|
| Brain | 2 | 2012 | 1268 | 0.300 |
Why?
|
| Spatial Behavior | 1 | 2007 | 22 | 0.300 |
Why?
|
| Stereotyped Behavior | 1 | 2006 | 20 | 0.300 |
Why?
|
| Autistic Disorder | 1 | 2006 | 37 | 0.280 |
Why?
|
| Sex Characteristics | 2 | 2004 | 213 | 0.270 |
Why?
|
| Mice | 8 | 2012 | 5668 | 0.270 |
Why?
|
| Social Behavior | 1 | 2006 | 124 | 0.270 |
Why?
|
| Sulfones | 1 | 2005 | 40 | 0.270 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2005 | 41 | 0.270 |
Why?
|
| Learning | 2 | 2019 | 108 | 0.270 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 283 | 0.260 |
Why?
|
| Biogenic Monoamines | 1 | 2004 | 30 | 0.250 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2005 | 155 | 0.240 |
Why?
|
| Universities | 2 | 2019 | 363 | 0.240 |
Why?
|
| Acetylcholine | 1 | 2003 | 68 | 0.230 |
Why?
|
| Entrepreneurship | 1 | 2023 | 5 | 0.230 |
Why?
|
| Animals | 10 | 2019 | 14307 | 0.220 |
Why?
|
| Gene Expression | 1 | 2005 | 639 | 0.220 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2019 | 4 | 0.180 |
Why?
|
| Age Factors | 4 | 2009 | 1007 | 0.180 |
Why?
|
| Temperament | 1 | 2019 | 29 | 0.180 |
Why?
|
| Technology | 1 | 2019 | 15 | 0.180 |
Why?
|
| Organ Size | 2 | 2012 | 148 | 0.180 |
Why?
|
| Writing | 1 | 2019 | 33 | 0.170 |
Why?
|
| Sex Factors | 3 | 2007 | 859 | 0.170 |
Why?
|
| Models, Animal | 2 | 2012 | 131 | 0.160 |
Why?
|
| Research Personnel | 2 | 2021 | 133 | 0.160 |
Why?
|
| Male | 9 | 2019 | 18870 | 0.150 |
Why?
|
| Receptors, Glutamate | 2 | 2006 | 26 | 0.130 |
Why?
|
| Motor Activity | 2 | 2009 | 393 | 0.130 |
Why?
|
| Female | 7 | 2019 | 19873 | 0.130 |
Why?
|
| Inflammation | 1 | 2019 | 577 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 605 | 0.130 |
Why?
|
| Congresses as Topic | 1 | 2014 | 38 | 0.120 |
Why?
|
| Functional Laterality | 2 | 2004 | 75 | 0.120 |
Why?
|
| Research | 1 | 2014 | 159 | 0.110 |
Why?
|
| Corticosterone | 1 | 2012 | 73 | 0.110 |
Why?
|
| Aggression | 1 | 2012 | 75 | 0.100 |
Why?
|
| Phenotype | 2 | 2019 | 650 | 0.100 |
Why?
|
| Corpus Striatum | 2 | 2009 | 99 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1056 | 0.090 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2009 | 63 | 0.080 |
Why?
|
| Matched-Pair Analysis | 1 | 2007 | 9 | 0.080 |
Why?
|
| Sympatholytics | 1 | 2007 | 13 | 0.080 |
Why?
|
| Methamphetamine | 1 | 2009 | 155 | 0.080 |
Why?
|
| Oxidopamine | 1 | 2007 | 18 | 0.080 |
Why?
|
| Denervation | 1 | 2007 | 26 | 0.080 |
Why?
|
| Reflex | 1 | 2007 | 31 | 0.080 |
Why?
|
| Morphogenesis | 1 | 2007 | 48 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2007 | 120 | 0.070 |
Why?
|
| Drug Administration Routes | 1 | 2005 | 12 | 0.070 |
Why?
|
| Rats | 2 | 2019 | 3261 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 1300 | 0.070 |
Why?
|
| Uterus | 1 | 2005 | 54 | 0.070 |
Why?
|
| Anxiety | 1 | 2012 | 705 | 0.070 |
Why?
|
| Humans | 3 | 2023 | 34853 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2004 | 134 | 0.060 |
Why?
|
| United States | 1 | 2014 | 3894 | 0.060 |
Why?
|
| Hippocampus | 1 | 2007 | 546 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2004 | 528 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2004 | 406 | 0.050 |
Why?
|
| Maryland | 1 | 2021 | 53 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1152 | 0.050 |
Why?
|
| Pregnancy | 1 | 2005 | 1503 | 0.050 |
Why?
|
| Multilevel Analysis | 1 | 2019 | 16 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2019 | 80 | 0.040 |
Why?
|
| Problem Solving | 1 | 2019 | 33 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2019 | 140 | 0.040 |
Why?
|
| Linear Models | 1 | 2019 | 253 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 200 | 0.040 |
Why?
|
| Self Efficacy | 1 | 2019 | 173 | 0.040 |
Why?
|
| Curriculum | 1 | 2019 | 237 | 0.040 |
Why?
|
| Motivation | 1 | 2019 | 415 | 0.030 |
Why?
|
| Presynaptic Terminals | 1 | 2009 | 52 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2009 | 101 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2009 | 165 | 0.020 |
Why?
|
| Aging | 1 | 2009 | 639 | 0.020 |
Why?
|